Search filters

List of works by Steven M Horwitz

18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma.

scientific article published on 04 March 2013

2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

scientific article published on 01 January 2019

944OBRENTUXIMAB VEDOTIN IN COMBINATION WITH CHP IN PATIENTS (PTS) WITH NEWLY-DIAGNOSED CD30+ PERIPHERAL T-CELL LYMPHOMAS (PTCL): 2-YEAR FOLLOW-UP

scientific article published in September 2014

A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score

scientific article published in July 2010

A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patients

scientific article published in June 2009

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial

scientific article

A prospective cohort study of patients with peripheral T-cell lymphoma in the United States

scientific article

A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission.

scientific article

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.

scientific article

Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma

scientific article published on 15 February 2019

Activity of the PI3K-δ,γ inhibitor duvelisib in a phase I trial and preclinical models of T-cell lymphoma

scientific article

Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States

scientific article published on 10 January 2017

Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL).

scientific article published on 28 August 2015

Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma

scientific article published on 01 January 2019

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

scientific article

Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.

scientific article published on 15 October 2011

Biomarker Quality Assurance (QA) Findings From the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE) Registry

article published in 2012

Breast implant-associated anaplastic large cell lymphoma: Clinical and imaging findings at a large US cancer center

scientific article published on 06 December 2018

Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma.

scientific article published on 25 July 2016

Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study

scientific article

Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma

scientific article published on 06 March 2020

Central nervous system involvement in T-cell lymphoma: A single center experience

scientific article published on 04 April 2016

Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

scientific article published on 26 April 2020

Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015

scientific article published on March 2015

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

scientific article

Clinical roundtable monograph. Current management and treatment of T-cell lymphoma: A multidisciplinary approach

scientific article published on 01 June 2010

Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation

scientific article published on 18 April 2019

Communication between oncologists and lymphoma survivors during follow-up consultations: A qualitative analysis

scientific article published on 30 March 2017

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma

scientific article published on 30 November 2015

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

scientific article published on 05 October 2015

Cutaneous T-cell lymphoma (CTCL), rare subtypes: five case presentations and review of the literature

scientific article published on 21 November 2018

Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome

scientific article published on 01 September 2014

Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective study

scientific article published on 8 November 2014

Diffuse Large B-Cell Lymphoma Version 1.2016

scientific article published on 01 February 2016

Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies

scientific article published on 30 November 2017

Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study

scientific article published on 20 October 2018

Efficacy of a survivorship-focused consultation versus a time-controlled rehabilitation consultation in patients with lymphoma: a cluster randomized controlled trial

scientific article published on 18 October 2018

Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population

scientific article published on 17 May 2016

Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial

scientific article published on 18 September 2017

Fear of cancer recurrence in lymphoma survivors: A descriptive study

scientific article published on 16 October 2019

Five-Year Outcomes for Frontline Brentuximab Vedotin with CHP for CD30 Expressing Peripheral T-Cell Lymphomas

scientific article published on 5 March 2018

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

scientific article published in October 2017

How I treat breast implant-associated anaplastic large cell lymphoma.

scientific article published on 12 September 2018

How I treat the peripheral T-cell lymphomas

scientific article published on 10 March 2014

Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma ⬇️

scientific article published on March 6, 2012

Immunotherapy in mycosis fungoides: opening night or dress rehearsal?

scientific article published on 11 January 2019

Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay.

scientific article published on 12 June 2018

Lenalidomide in Adult T-Cell Leukemia/Lymphoma

scientific article published on 31 October 2016

Long-term follow-up and management of small and medium-sized CD4+ T cell lymphoma and CD8+ lymphoid proliferations of acral sites: a multicenter experience

scientific article published on July 2016

Long‐term follow‐up and survival of cutaneous T‐cell lymphoma patients treated with extracorporeal photopheresis ⬇️

scientific article published on 01 October 2012

Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides

scientific article published on 21 April 2016

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

scientific article published on 09 August 2018

Multicenter case series of indolent small/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face

scientific article published on 01 May 2014

Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors

scientific article published on December 2014

Mycosis fungoides, Psoriasis and Anti-PD-1 - A New Aspect of Known Associations

scientific article published on 14 December 2018

Mycosis fungoides, Psoriasis und PD-1-Inhibitoren - neuer Aspekt einer bekannten Assoziation

scientific article published on 01 February 2019

NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas

scientific article

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017.

scientific article

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

scientific article

Non-Hodgkin's Lymphomas, version 3.2012

scientific article published on 01 December 2012

Non-Hodgkin's lymphomas

scientific article published on 01 April 2008

Non-Hodgkin's lymphomas

scientific article published on 01 May 2011

Non-Hodgkin's lymphomas, version 1.2013.

scientific article

Non-Hodgkin's lymphomas, version 2.2014

scientific article published on 01 June 2014

Non-Hodgkin's lymphomas, version 4.2014.

scientific article published on September 2014

Novel Immunotherapies for T Cell Lymphoma and Leukemia

scientific article published on 01 December 2018

Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin.

scientific article published on 20 March 2014

PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study

scientific article published on 13 February 2015

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network

scientific article published on 19 April 2018

Peripheral T-cell lymphoma – are we making progress?

scientific article published on 17 July 2018

Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.

scientific article

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project

scientific article published on 20 July 2015

Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma

scientific article

Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies

scientific article published on 3 August 2009

Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma

scientific article published on 01 April 2018

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study

scientific article

Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile

scientific article published on 12 June 2018

Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification

scientific article

Primary cutaneous B-cell lymphomas: part II. Therapy and future directions

scientific article

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers

scientific article published on February 2014

Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab

scientific article published on 14 June 2017

Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study

scientific article published on 15 February 2011

Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma

scientific article published on 5 September 2017

Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma

scientific article published on 30 December 2015

Protocol for a cluster randomised trial of a communication skills intervention for physicians to facilitate survivorship transition in patients with lymphoma

scientific article published on 28 June 2016

Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma

scientific article published on 16 December 2016

Results from a Phase I/II Open-Label, Dose-Finding Study of Pralatrexate and Oral Bexarotene in Patients with Relapsed/Refractory Cutaneous T-cell Lymphoma.

scientific article

Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial

scientific article published on 13 February 2003

Role of Single Agent and Combination Chemotherapy Strategies in Relapsed/Refractory Peripheral T-Cell Lymphoma: Results from the Complete Registry

Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial

scientific article published on 10 March 2016

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses

scientific article

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

scientific article published on 12 July 2016

Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials

scientific article published on 07 March 2017

Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients

scientific article published on 25 September 2018

Survivorship care planning after participation in communication skills training intervention for a consultation about lymphoma survivorship

scientific article

Symptomatic delayed seromas vs incidental findings on MR, and likelihood of BIA-ALCL in women with textured implants

Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma

scientific article

T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment

scientific article published on 31 December 2016

T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders

scientific article published on 27 July 2018

Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features

scientific article published on 09 November 2020

Targeting histone deacetylases in T-cell lymphoma

scientific article published on 4 November 2016

The Genetic Basis of Hepatosplenic T-cell Lymphoma.

scientific article published on 25 January 2017

The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma

scientific article

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

scientific article published on April 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

scientific article published on 11 July 2016

The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: are we there yet?

scientific article published on 10 October 2017

The outcome of peripheral T-cell lymphoma patients failing first line therapy: a report from the prospective, international T-Cell project.

scientific article published on 29 March 2018

Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma

scientific article

Treatment of Rosai–Dorfman disease with oral bexarotene: a case series

scientific article published on 19 November 2018

Treatment of Vulvar Mycosis Fungoides Tumors With Localized Radiotherapy

scientific article published on 04 May 2018

Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma.

scientific article

mTOR inhibition in T-cell lymphoma: a path(way) forward.

scientific article

Paulina is supported by:

About Paulina

Help